Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cansortiuminc (TIUM-U.CN)

Cansortiuminc (TIUM-U.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cansortiuminc 82 North East 26th Street Suite 110 Miami FL 33137 USA

https://getfluent.com P: 305-441-9085

Description:

Cansortium Inc is licensed to produce and sell medical cannabis in Florida and Texas and is licensed to sell medical cannabis in Pennsylvania. Its medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flowers, pre-rolls, cartridges, and edibles. All of the company's products are marketed under the Fluent brand name. In Pennsylvania, the company's product portfolio is comprised of a variety of third-party branded medical cannabis products.

Key Statistics

Overview:

Market Capitalization, $K 44,002
Shares Outstanding, K 275,011
Annual Sales, $ 87,692 K
Annual Net Income, $ -37,423 K
Last Quarter Sales, $ 25,260 K
Last Quarter Net Income, $ -2,761 K
60-Month Beta 1.32
% of Institutional Shareholders 0.07%

Growth:

1-Year Return 113.33%
3-Year Return -85.05%
5-Year Return -90.00%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm -0.09
EPS Growth vs. Prev Year 11.11%
Dividend Payout Ratio 0.00%

TIUM-U.CN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -95.56%
Return-on-Assets % -13.72%
Profit Margin % -42.68%
Debt/Equity 3.30
Price/Sales 0.57
Price/Book 2.81
Book Value/Share 0.06
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar